246 related articles for article (PubMed ID: 25549950)
1. The role of tumour budding in predicting survival in patients with primary operable colorectal cancer: a systematic review.
van Wyk HC; Park J; Roxburgh C; Horgan P; Foulis A; McMillan DC
Cancer Treat Rev; 2015 Feb; 41(2):151-9. PubMed ID: 25549950
[TBL] [Abstract][Full Text] [Related]
2. The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
van Wyk HC; Park JH; Edwards J; Horgan PG; McMillan DC; Going JJ
Br J Cancer; 2016 Jul; 115(2):156-63. PubMed ID: 27299960
[TBL] [Abstract][Full Text] [Related]
3. Tumour budding as prognostic factor in stage I/II colorectal carcinoma.
Prall F; Nizze H; Barten M
Histopathology; 2005 Jul; 47(1):17-24. PubMed ID: 15982319
[TBL] [Abstract][Full Text] [Related]
4. Tumour budding at invasive margins and outcome in colorectal cancer.
Kanazawa H; Mitomi H; Nishiyama Y; Kishimoto I; Fukui N; Nakamura T; Watanabe M
Colorectal Dis; 2008 Jan; 10(1):41-7. PubMed ID: 18078460
[TBL] [Abstract][Full Text] [Related]
5. The role of perineural invasion in predicting survival in patients with primary operable colorectal cancer: A systematic review.
van Wyk HC; Going J; Horgan P; McMillan DC
Crit Rev Oncol Hematol; 2017 Apr; 112():11-20. PubMed ID: 28325252
[TBL] [Abstract][Full Text] [Related]
6. Tumour budding intensity in relation to cathepsin D expression and some clinicopathological features of colorectal cancer.
Famulski W; Guzińska-Ustymowicz K; Sulkowska M; Chabowski A; Zalewski B; Piotrowski Z; Stasiak-Barmuta A; Sulkowski S
Folia Histochem Cytobiol; 2001; 39 Suppl 2():171-2. PubMed ID: 11820592
[TBL] [Abstract][Full Text] [Related]
7. Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis.
Petrelli F; Pezzica E; Cabiddu M; Coinu A; Borgonovo K; Ghilardi M; Lonati V; Corti D; Barni S
J Gastrointest Cancer; 2015 Sep; 46(3):212-8. PubMed ID: 25994502
[TBL] [Abstract][Full Text] [Related]
8. Role of APAF-1, E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer.
Zlobec I; Lugli A; Baker K; Roth S; Minoo P; Hayashi S; Terracciano L; Jass JR
J Pathol; 2007 Jul; 212(3):260-8. PubMed ID: 17516584
[TBL] [Abstract][Full Text] [Related]
9. Tumour budding is a strong and independent prognostic factor in pancreatic cancer.
Karamitopoulou E; Zlobec I; Born D; Kondi-Pafiti A; Lykoudis P; Mellou A; Gennatas K; Gloor B; Lugli A
Eur J Cancer; 2013 Mar; 49(5):1032-9. PubMed ID: 23177090
[TBL] [Abstract][Full Text] [Related]
10. Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer.
Karamitopoulou E; Lugli A; Panayiotides I; Karakitsos P; Peros G; Rallis G; Patsouris ES; Terracciano L; Zlobec I
Histopathology; 2010 Aug; 57(2):233-43. PubMed ID: 20716165
[TBL] [Abstract][Full Text] [Related]
11. Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer.
Rogers AC; Winter DC; Heeney A; Gibbons D; Lugli A; Puppa G; Sheahan K
Br J Cancer; 2016 Sep; 115(7):831-40. PubMed ID: 27599041
[TBL] [Abstract][Full Text] [Related]
12. Tumour budding in colorectal cancer: what do we know and what can we do?
De Smedt L; Palmans S; Sagaert X
Virchows Arch; 2016 Apr; 468(4):397-408. PubMed ID: 26613731
[TBL] [Abstract][Full Text] [Related]
13. The Relationship Between Tumor Budding, Tumor Microenvironment, and Survival in Patients with Primary Operable Colorectal Cancer.
van Wyk HC; Roseweir A; Alexander P; Park JH; Horgan PG; McMillan DC; Edwards J
Ann Surg Oncol; 2019 Dec; 26(13):4397-4404. PubMed ID: 31605345
[TBL] [Abstract][Full Text] [Related]
14. Tumor budding in colorectal carcinoma assessed by cytokeratin immunostaining and budding areas: possible involvement of c-Met.
Satoh K; Nimura S; Aoki M; Hamasaki M; Koga K; Iwasaki H; Yamashita Y; Kataoka H; Nabeshima K
Cancer Sci; 2014 Nov; 105(11):1487-95. PubMed ID: 25220207
[TBL] [Abstract][Full Text] [Related]
15. Tumour budding in colorectal carcinoma.
Prall F
Histopathology; 2007 Jan; 50(1):151-62. PubMed ID: 17204028
[TBL] [Abstract][Full Text] [Related]
16. Tumour budding: a promising parameter in colorectal cancer.
Lugli A; Karamitopoulou E; Zlobec I
Br J Cancer; 2012 May; 106(11):1713-7. PubMed ID: 22531633
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic reproducibility of tumour budding in colorectal cancer: a multicentre, multinational study using virtual microscopy.
Puppa G; Senore C; Sheahan K; Vieth M; Lugli A; Zlobec I; Pecori S; Wang LM; Langner C; Mitomi H; Nakamura T; Watanabe M; Ueno H; Chasle J; Conley SA; Herlin P; Lauwers GY; Risio M
Histopathology; 2012 Oct; 61(4):562-75. PubMed ID: 22765314
[TBL] [Abstract][Full Text] [Related]
18. Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer.
Horcic M; Koelzer VH; Karamitopoulou E; Terracciano L; Puppa G; Zlobec I; Lugli A
Hum Pathol; 2013 May; 44(5):697-705. PubMed ID: 23159156
[TBL] [Abstract][Full Text] [Related]
19. Aggressive colorectal carcinoma phenotypes of invasion can be assessed reproducibly and effectively predict poor survival: interobserver study and multivariate survival analysis of a prospectively collected series of 299 patients after potentially curative resections with long-term follow-up.
Wöhlke M; Schiffmann L; Prall F
Histopathology; 2011 Nov; 59(5):857-66. PubMed ID: 22092397
[TBL] [Abstract][Full Text] [Related]
20. The relationship between tumor budding and survival in colorectal carcinomas.
Ozer SP; Barut SG; Ozer B; Catal O; Sit M
Rev Assoc Med Bras (1992); 2019 Dec; 65(12):1442-1447. PubMed ID: 31994623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
